0 Комментарии
0 Поделились
223 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Reels
-
Статьи пользователей
-
Маркет
-
Offers
-
Jobs
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Exosome Diagnostic and Therapeutics Market – Extracellular Vesicles Advancing Liquid Biopsy ScienceMarket Overview The exosome diagnostic and therapeutics market is expanding as researchers increasingly recognize extracellular vesicles as valuable carriers of biomarker information and potential therapeutic delivery vehicles. Exosomes shed by cells into biological fluids carry proteins, nucleic acids, and lipids reflecting their cell of origin, making them attractive candidates for...0 Комментарии 0 Поделились 265 Просмотры 0 предпросмотр
-
Liquid Biopsy Market to Reach USD 29.2 Billion by 2036 as Precision Oncology and Non-Invasive Cancer Testing Drive Global GrowthThe global Liquid Biopsy Market is poised for substantial expansion as healthcare providers increasingly adopt minimally invasive cancer diagnostic technologies for early detection, treatment monitoring, and personalized medicine. According to the latest industry analysis, the global Liquid Biopsy Market is projected to grow from USD 7.3 billion in 2026 to USD 29.2 billion by 2036, registering...0 Комментарии 0 Поделились 348 Просмотры 0 предпросмотр
-
Liquid Biopsy Market Value, Demand and Competitive Industry InsightsLiquid biopsy has emerged as a transformative technology in modern oncology and precision medicine. The growing demand for non-invasive diagnostic techniques, rising prevalence of cancer worldwide, and increasing adoption of personalized medicine are significantly contributing to market growth. Liquid biopsy enables the detection of cancer biomarkers through blood samples, eliminating the need...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Liquid Tumor Biopsy Market Driven By Non Invasive Diagnostic SolutionsThe Liquid Tumor Biopsy Market growth continues to accelerate as precision oncology increasingly shifts toward non-invasive, real-time monitoring of cancer progression and treatment response. With rising global cancer incidence and growing demand for alternatives to traditional tissue biopsies—which are often invasive, painful, and geographically constrained—the adoption of...0 Комментарии 0 Поделились 335 Просмотры 0 предпросмотр
-
US Cancer Test Market Growth: Liquid Biopsy Takes Center StageThe US cancer test market is advancing as greater emphasis is placed on early detection, accurate diagnosis, and personalized cancer care. Increasing adoption of molecular diagnostics, biomarker testing, liquid biopsy, and advanced screening technologies is helping clinicians identify cancer and characterize disease more precisely. Continued innovation in diagnostic platforms and growing...0 Комментарии 0 Поделились 182 Просмотры 0 предпросмотр
-
Companion Diagnostics Market Growth Through Biomarker-Guided TreatmentThe companion diagnostics market is becoming an increasingly important link between diagnosis and treatment. Instead of asking only whether a disease is present, modern healthcare is increasingly asking a more specific question: which therapy is most appropriate for this patient? That change is reshaping the role of diagnostics. A biomarker can now influence whether a targeted drug is...0 Комментарии 0 Поделились 242 Просмотры 0 предпросмотр
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek